Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | MEN1 | O00255 | 3/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | NQO2 | P16083 | 2/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | TOP2A | P11388 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenazine SCHEMBL1226523 | 1.00 | POLB (0.42) | POLBMAPTKDM4EGLALMNA | |
| SCHEMBL10674809 | 0.86 | ALDH1A1 (0.43) | POLBMAPTKDM4ELMNAHSD17B10 | |
| SCHEMBL31578887 | 0.84 | NQO2 (0.65) | POLBMAPTKDM4ELMNAMEN1 | |
| Phenazine SCHEMBL28658053 | 0.83 | MAPT (0.55) | POLBMAPTKDM4ELMNAMEN1 | |
| Quinoline SCHEMBL28332577 | 0.83 | ALDH1A1 (0.53) | MAPTKDM4ELMNAHSD17B10MEN1 | |
| Phenazine SCHEMBL8936740 | 0.82 | NQO2 (0.61) | POLBMAPTKDM4ELMNAMEN1 | |
| SCHEMBL8585681 | 0.81 | NQO2 (0.46) | POLBMAPTKDM4ELMNAMEN1 | |
| SCHEMBL8585680 | 0.81 | NQO2 (0.48) | POLBMAPTKDM4EGLALMNA | |
| Catechol SCHEMBL23541091 | 0.80 | CA2 (0.42) | POLBMAPTKDM4ELMNAHSD17B10 | |
| Phenazine SCHEMBL2873102 | 0.79 | MAPT (0.50) | POLBMAPTKDM4ELMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210246485-A1 | HISTAMINE MEASUREMENT METHOD AND KIT | KIKKOMAN CORPORATION (JP) | 2021-08-12 | — | — | US | claimed |
| WO-2020040113-A1 | HISTAMINE MEASUREMENT METHOD AND KIT | キッコーマン株式会社 | 2020-02-27 | — | — | WO | claimed |
| US-12565672-B2 | Sampling method and kit for histamine measurement | KIKKOMAN CORPORATION (JP) | 2026-03-03 | — | — | US | disclosed |
| EP-3842804-B1 | SAMPLING METHOD AND KIT FOR HISTAMINE MEASUREMENT | KIKKOMAN CORP (JP) | 2025-01-22 | — | — | EP | disclosed |
| US-20210310042-A1 | SAMPLING METHOD AND KIT FOR HISTAMINE MEASUREMENT | KIKKOMAN CORPORATION (JP) | 2021-10-07 | — | — | US | disclosed |
| US-20210246485-A1 | HISTAMINE MEASUREMENT METHOD AND KIT | KIKKOMAN CORPORATION (JP) | 2021-08-12 | — | — | US | disclosed |
| EP-3842804-A1 | SAMPLING METHOD AND KIT FOR HISTAMINE MEASUREMENT | Kikkoman Corporation (JP) | 2021-06-30 | — | — | EP | disclosed |
| WO-2020040116-A1 | SAMPLING METHOD AND KIT FOR HISTAMINE MEASUREMENT | キッコーマン株式会社 | 2020-02-27 | — | — | WO | disclosed |
| WO-2020040113-A1 | HISTAMINE MEASUREMENT METHOD AND KIT | キッコーマン株式会社 | 2020-02-27 | — | — | WO | disclosed |
| EP-0354441-B1 | Method for the colorimetric determination of analyte using enzymatic oxydation | BOEHRINGER MANNHEIM GMBH (DE) | 1995-05-17 | — | — | EP | disclosed |
| EP-0354441-A2 | Method for the colorimetric determination of analyte using enzymatic oxydation | Roche Diagnostics GmbH (DE) | 1990-02-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210246485-A1 | HISTAMINE MEASUREMENT METHOD AND KIT | HRH2, KIT, HRH3 | POLB 1349/4885MAPT 4628/4885KDM4E 1108/4885 |
| US-12565672-B2 | Sampling method and kit for histamine measurement | HNMT, CMA1, KIT | POLB 3119/4885MAPT 3279/4885KDM4E 123/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.